Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples